RPB0127

Pathogen Description

Target Pathogen Pathogen Name NCBI Taxonomy ID Order Family Genus Species Pathogen type
RSV A/B Respiratory syncytial virus, Respiratory syncytial virus RS, respiratory syncytial virus RS virus, Respiratory syncytial virus RSV 12814 Mo\gavirales Pneumoviridae Orthopneumovirus Bovine orthopneumovirus Virus

Primer Description

Primer Name Sequence(5'-3') Length(bp) Primer Final Concentration(μM) GC Content(%) Predicted Melting Temperature(℃) Molecular Weight(g/moles) Positions in GenBank accession number
RSV B-RPA-F TAATCCAACTTCCAAAAAATTGAGTGACTTG 31 0.48 32.3 55.23 9486.27 \
RSV B-RPA-R TGTTTTATTGATGTTGTTGATTGCTGAGTG 30 0.48 33.3 55.59 9310.09 \

Gene Description

Target Gene GenBank ID
\ \

Assay Description

Application Assay Primer Designing Software Reaction Time(min) Assay Temperature(℃) Readout System(s) Limit of Detection(LoD) Sensitivity(%) Specificity(%)
Detection of Respiratory Syncytial Virus A or B RPA Premier Biosoft designer 37 39 CRISPR/Cas12a-fluorescence 1.38 × 10¹ copies/μl 0.4286 0.9333

Publication Description

Year of Publication Title Author(s) Journal PMID DOI
2022 Integrated Trinity Test With RPA-CRISPR/Cas12a-Fluorescence for Real-Time Detection of Respiratory Syncytial Virus A or B Ling Gong,Xiaowen Wang,Zhu Li,Guichuan Huang,Wei Zhang,Jin Nie,Chunyan Wu,Daishun Liu Frontiers in microbiology 35432263 10.3389/fmicb.2022.819931

Integrated Trinity Test With RPA-CRISPR/Cas12a-Fluorescence for Real-Time Detection of Respiratory Syncytial Virus A or B

Author(s):

Ling Gong,Xiaowen Wang,Zhu Li,Guichuan Huang,Wei Zhang,Jin Nie,Chunyan Wu,Daishun Liu

Journal:

Frontiers in microbiology

Year:

2022

Abstract:

Respiratory syncytial virus (RSV) is a common virus that causes respiratory infection, especially severe respiratory infection in infants and young children, the elderly people over 65 years old, and people with weak immunity. Currently, RSV infection has no effective vaccine and antiviral treatment. The number of deaths due to RSV infection increases every year. Moreover, RSV A infection occurs in a large number and has severe clinical symptoms and complications than RSV B infection. Therefore, the development of a simple, rapid, and inexpensive detection method with high amplification efficiency, high sensitivity, and specificity is very important for the diagnosis of RSV A or RSV B infection, which can help in the early clinical medication and prevent the progress of the disease. Therefore, we developed an integrated trinity test with an RPA-CRISPR/Cas12a-fluorescence (termed IT-RAISE) assay system to detect RSV A or RSV B. The characteristic of the IT-RAISE system is that after target recognition, the reporter single-stranded DNA (ssDNA) is cleaved by Cas12a that is activated by different crRNAs to detect the generated fluorescent signal. This method is simple and helps in adding all reagents rapidly. It is a high-sensitive method that can detect 1.38 × 101 copies/μl of the target sequences, and it can distinguish RSV A or RSV B infection within 37 min. In addition, clinical specimens were detected for IT-RAISE system. It was found that the sensitivity and specificity of RSV A were 73.08 and 90%, respectively, and those of RSV B were 42.86 and 93.33%, respectively. The cost of ONE specimen for IT-RAISE system was approximately $ 2.6 (excluding rapid RNA extraction and reverse transcription costs). IT-RAISE system has good clinical application prospects for detecting RSV A or RSV B infection; it is a simple, rapid, and inexpensive method with high amplification efficiency, high sensitivity, and high specificity. The IT-RAISE system might also detect other viral or bacterial infections.